State‐of‐the‐art 2023 on gene therapy for phenylketonuria is a research paper published in Journal of Inherited Metabolic Disease (2023). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Swiss National Science Foundation
Grant: 310030‐162547
NICHD NIH HHS
Grant: U54 HD100982
Swiss National Science Foundation
Grant: 310030-162547
Swiss National Science Foundation
Grant: CRSII5_180257
Swiss National Science Foundation
Grant: 310030
Swiss National Science Foundation
Grant: 214936
Establishment of high-precision and miniature genome editors for clinical applications
Swiss National Science Foundation
Grant: 180257
Development of novel synthetic gene transfer vectors for metabolic liver therapy
Swiss National Science Foundation
Grant: 185293
Establishment of in vivo CRISPR-Cas base editor approaches to treat monogenetic liver diseases
National Institutes of Health
Grant: 5U54HD100982-03
Hyperphenylalaninemia Disorders Consortium of the Rare Disease Clinical Research Network
National PKU Alliance
National Institutes of Health
NIH HHS
FWCI
5.12
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals